1. Assess the need for invasive mechanical ventilation
The need for intubation should be evaluated by case-to-case basis, and it is particularly difficult to outline exact objective criteria. However, the following may be used as a guide.
|
Apnea or impending respiratory arrest. |
|
Acute exacerbation of COPD or acute severe asthma with dyspnea, tachypnea, and acute respiratory acidosis (hypercapnia and decreased arterial pH) plus at least one of the following: ● Acute cardiovascular instability. ● Altered mental status or persistent uncooperativeness. ● Inability to protect the lower airway. ● Copious or unusually viscous secretions. ● Abnormalities of the face or upper airway that would prevent effective noninvasive positive pressure ventilation. |
|
Acute ventilatory insufficiency in cases of neuromuscular disease accompanied by any of the following: ● Acute respiratory acidosis (hypercapnia and decreased arterial pH). ● Progressive decline in vital capacity to below 10 to15 mL/kg. ● Progressive decline in maximum inspiratory pressure to below −20 to −30 cm H2O. |
|
Acute hypoxemic respiratory failure with tachypnea, respiratory distress, and persistent hypoxemia despite administration of a high fraction of inspired oxygen (FiO2) with high-flow oxygen devices or in the presence of any of the following: ● Acute cardiovascular instability. ● Altered mental status or persistent uncooperativeness. ● Inability to protect the lower airway. |
|
Need for endotracheal intubation to maintain or protect the airway, like in patients with low GCS, or to manage secretions. |
2. Initial Settings in Mechanical Ventilation
A single technique may not be applicable to all the different conditions for which invasive mechanical ventilation is indicated, however, for most patients the following protocol could be used.
2.1. Calculate predicted body weight (PBW)
Males: PBW= 50 + 2.3 [height (inches) - 60]
Females: PBW= 45.5 + 2.3 [height (inches) -60]
2.2. Calculate minute ventilation (VE) using body surface area (BSA)
Males: BSA x 4
Females: BSA x 3.5
2.3. Select Mode
|
Assist/control mode is the preferred ventilator mode for most conditions. The name may vary depending on the type of ventilator (e.g., Draeger- IPPV assist, SCMV, Vol A/C). |
|
Decision on whether to put pressure control ventilation (PCV) or volume control ventilation (VCV) depends on the operator and institutional preference. In Nepal. First preferred mode is Volume Assist Control. |
2.4. Set Tidal Volume (VT)
|
V T is commonly set at 6 ml/kg of predicted body weight (PBW). |
|
In PCV, the pressure control should be adjusted to achieve the target V T. |
2.5. Set Respiratory Rate (RR)
|
Respiratory rate (RR) is set to achieve the target minute ventilation (VE). RR= VE/ V T E.g., if target V E is 6 L and target V T is 300 ml then RR is set at 6000/300= 20 breaths/min. |
|
For obstructive airway diseases (e.g., COPD), initial RR should be kept low at 8-12 breaths/min to avoid air trapping and generation of auto PEEP. |
2.6. Set FiO 2
|
Start with FiO 2 of 100%. |
|
Once stable, titrate to the lowest FiO 2 required to achieve adequate oxygenation. Targets may vary according to disease condition (e.g., ARDS: PaO2≥55mmHg or SPO2≥ 88%; TBI: SPO2≥ 94%). |
2.7. Set PEEP
|
Start with a minimum PEEP of 5 cm H2O. |
|
Adjust to the lowest PEEP required to achieve adequate oxygenation. |
|
Many methods of setting PEEP; most common technique is to use the PEEP- FiO 2 table of ARDSnet trial. |
|
Lower PEEP may be required in obstructive airway diseases without spontaneous breathing. |
|
PEEP selection can be done from one of the following tables. In Nepal, we commonly use lower PEEP/higher FiO2(Table 1). |
Table 1: Lower PEEP/higher FiO 2
|
FiO 2 |
0.3 |
0.4 |
0.4 |
0.5 |
0.5 |
0.6 |
0.7 |
0.7 |
0.7 |
0.8 |
0.9 |
0.9 |
0.9 |
1.0 |
|
PEEP (cmH20) |
5 |
5 |
8 |
8 |
10 |
10 |
10 |
12 |
14 |
14 |
14 |
16 |
18 |
18-24 |
Table 2: Higher PEEP/lower FiO 2
|
FiO 2 |
0.3 |
0.3 |
0.3 |
0.3 |
0.3 |
0.4 |
0.4 |
0.5 |
0.5 |
0.5-0.8 |
0.8 |
0.9 |
1.0 |
1.0 |
|
PEEP (cmH20) |
5 |
8 |
10 |
12 |
14 |
14 |
16 |
16 |
18 |
20 |
22 |
22 |
22 |
18-24 |
In ICU Where MDs are available round the clock, PEEP has to be titrated based on optimal PEEP at least every 12 hourly and as needed.
2.8. Inspiratory time and I:E ratio
|
I:E ratio is set at 1:2. |
|
Higher ratio (1:1) may be required for better oxygenation and a lower ratio (1:3) may be required for carbon dioxide removal and for patients with obstructive airway disease (e.g., COPD). |
|
I:E ratio can be set directly in some ventilators (e.g., Maquet Servo); in some, this will be determined by setting the inspiratory time and RR (e.g., Drager Evita XL). |
3. Monitoring during invasive mechanical ventilation
Be vigilant of all audiovisual alarms of the ventilator, and always address the alarm.
3.1. Airway pressures
|
Keep plateau pressures (measured during inspiratory pause) < 30 cm H2O by decreasing Vt up to 4 ml/kg. |
|
Keep driving pressure (Pplat- PEEP) <14 cm of H2O by optimizing PEEP and VT. |
3.2. Ventilator scalars and loops
The ventilator scalars (waveforms) and loops provide a lot of information (e.g., resistance, compliance, asynchrony, air leak) at a glance and is one of the most important aspects of troubleshooting the ventilator.
3.3. Carbon dioxide
|
Adjust RR (maximum 35 breaths/min) as per the target CO2. This can be achieved by using the formula: Desired RR= Current RR x Current CO2/ Desired CO 2 |
|
Accept permissive hypercapnia while maintaining pH>7.2. Contraindication to permissive hypercapnia includes intracranial hypertension, acute coronary artery disease, arrhythmias, right heart failure and worsening pulmonary hypertension. |
3.4. Hemodynamics
Monitor blood pressure as initiation of positive pressure ventilation may cause hypotension.
4. Assess for Liberation from Mechanical Ventilation
4.1. Assessing Readiness to wean
|
Clinical criteria ● Resolution of disease ● Adequate cough and less amount of secretions
|
Objective criteria ● Adequate oxygenation ▪ SpO2≥ 90% or PaO 2 > 60 mmHg with PEEP ≤ 8 cm H2O and FiO2≤ 0.4. ▪ PaO2/FiO2≥ 150. ● Adequate Ventilation ▪ RR ≤ 35 breaths/min, generated VT>5 ml/kg, Vital capacity >10 ml/kg. ▪ No clinically significant respiratory acidosis. ● Stable Cardiovascular system ▪ HR < 140 bpm, stable blood pressure, or no to minimal pressors/ inotropes. ● Combined indices: Rapid shallow breathing index (RSBI) = RR/VT<105, where V T is in liter ● Adequate mentation: Arousable, GCS ≥13, no continuous sedative infusions. |
4.2. Spontaneous Breathing Trial (SBT)
|
Once a patient is assessed to be ready to wean, SBT should be performed daily using any of the methods- PSV, CPAP, T-piece, ATC (automatic tube compensation) |
|
PSV of ≤ 8 for half an hour (maximum 2 hours) is the preferred method in most cases of first weaning trial. |
|
Assess for tolerance as below ● SpO 2 ≥ 90 and/or PaO 2 ≥ 60 mmHg. ● Spontaneous V T ≥ 4 ml/kg PBW. ● RR ≤ 35/min. ● pH ≥ 7.3 ● No respiratory distress (Absence of 2 or more of following: HR > 120% of baseline; Marked accessory muscle use; Abdominal paradox; Diaphoresis; Marked dyspnea). |
4.3. Extubation
|
If the patient’s SBT is successful, extubation can be performed if there is strong cough. |
|
Cuff leak is performed for patients with high risk of subglottic edema, which include ● Traumatic intubation. ● Intubation >6 days. ● Reintubation after unplanned Extubation. ● Females. ● Large endotracheal tube for size. |
|
If extubation has to be postponed, reassessment for possible extubation should be done after 12 hours. |
4.4. Post-extubation Noninvasive ventilation
5. Use of preventive NIV is usually recommended for following patients
|
Obese patients. |
|
Those with moderate to severe COPD. |
|
Hypercapnia. |
|
> 2 failed SBT. |
|
Congestive heart failure. |
5.1. Post -extubation High Flow Nasal Cannula (HFNC)
HFNC use after extubation should be individualized and depend upon factors including oxygen requirement, the etiology of respiratory failure, and patient preferences.
Further Readings:
1. Slutsky, A. S. (1993). Mechanical ventilation. Chest, 104(6), 1833-1859.
2. Boles, J. M., Bion, J., Connors, A., Herridge, M., Marsh, B., Melot, C., & Welte, T. (2007). Weaning from mechanical ventilation. European Respiratory Journal, 29(5), 1033-1056.
3. Acute Respiratory Distress Syndrome Network. (2000). Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. New England Journal of Medicine, 342(18), 1301-1308.
4. National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. (2004). Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. New England Journal of Medicine, 351(4), 327-336.
5. Girard, T. D., Alhazzani, W., Kress, J. P., Ouellette, D. R., Schmidt, G. A., Truwit, J. D., & Morris, P. E. (2017). An official American Thoracic Society/American College of Chest Physicians clinical practice guideline: liberation from mechanical ventilation in critically ill adults. Rehabilitation protocols, ventilator liberation protocols, and cuff leak tests. American journal of respiratory and critical care medicine, 195(1), 120-133.